Asset sale Pending

ESTEVE acquisition of TerSera Infusion Specialty Therapies Business Unit (IST)

Announced 13 Jan 2026

Advisers

TerSera Infusion Specialty Therapies Business Unit (IST)

Target

Financial adviser

ESTEVE

Acquirer

Financial adviser
Legal adviser
Target
TerSera Infusion Specialty Therapies Business Unit (IST)
Acquirer
ESTEVE
Seller
TerSera Therapeutics
Target based in
United States (unverified)
Buyer based in
Spain
Seller based in
United States
Sector
Pharma

In the league tables

Similar deals

All pharma deals →

Sources

Suggest a correction

A missing adviser, a wrong role or a different outcome. A link to a public source helps.